Literature DB >> 30396173

Transoral Robotic Surgery Total Laryngectomy.

Georges Lawson1, Abie Mendelsohn2, Raja Fakhoury3, Sebastien Van der Vorst3, Marc Remacle3, Vincent Bachy3, Gilles Delahaut3.   

Abstract

OBJECTIVE: The aim of our study is to demonstrate our technique for performing transoral robotic surgical total laryngectomy (TORS-TL) with the use of the da Vinci robotic system.
MATERIALS AND METHODS: We provide a comprehensive description of the TORS-TL operative techniques. Two fresh-frozen human cadavers were selected after ethics approval to describe the appropriate step-by-step surgical resection. We adopted a 5-step procedure that was later applied to 2 of our patients. The first patient presented initially with a squamous cell carcinoma (SCC) in the laryngeal glottis area. A lack of clinical response to initial treatment by chemoradiotherapy led to the decision of performing salvage TL surgery. The second patient had a previous history of head and neck SCC (HNSCC); he had no recurrence of his primary tumor but suffered significantly from postoperative breathing and swallowing difficulties due to severe laryngeal incompetence.
RESULTS: TORS-TL was successfully performed in all cases. The operative time for the cadavers was approximately 65 and 55 min, respectively. It was significantly longer for the patients, 210 and 235 min, respectively, despite the fact that exactly the same steps were followed throughout all procedures. There were no intra- or postoperative complications or surgical morbidity related to the use of the da Vinci system.
CONCLUSION: TORS-SL for SCC was performed in a safe, reliable, and smooth manner and was shown to be successful in treating our patients. We thus believe that our step-by-step surgical technique for TORS-SL is efficient and reproducible.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Procedure; Total laryngectomy; Transoral robotic surgery; da Vinci robot

Mesh:

Year:  2018        PMID: 30396173     DOI: 10.1159/000490595

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  8 in total

1.  [Robotics in otorhinolaryngology, head and neck surgery].

Authors:  F Böhm; J Greve; R Riepl; T K Hoffmann; P J Schuler
Journal:  HNO       Date:  2021-07-16       Impact factor: 1.284

Review 2.  [Robot-assisted head and neck surgery].

Authors:  P J Schuler; F Boehm; L R Schild; J Greve; T K Hoffmann
Journal:  HNO       Date:  2021-02       Impact factor: 1.284

Review 3.  Role of Robotics in Non-oropharyngeal Head and Neck Tumours.

Authors:  Ravi Shankar; Aseem Mishra; Akshat Malik
Journal:  Indian J Surg Oncol       Date:  2022-02-27

4.  Transoral Laser-Assisted Total Laryngectomy: Expanding the TLM's World.

Authors:  Aslan Ahmadi; Saleh Mohebbi; Masoud Kazemi; Ayda Sanaei
Journal:  Case Rep Otolaryngol       Date:  2020-09-26

5.  Lateral cervical approach for salvage total laryngectomy without pharyngeal reinforcement with pedicled or free flaps: our preliminary experience in six patients.

Authors:  Fabio Ferreli; Giuseppe Mercante; Armando De Virgilio; Pasquale Di Maio; Oreste Iocca; Raul Pellini; Giuseppe Spriano
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-31       Impact factor: 2.503

Review 6.  Laryngeal Cancer Surgery: History and Current Indications of Transoral Laser Microsurgery and Transoral Robotic Surgery.

Authors:  Stéphane Hans; Robin Baudouin; Marta P Circiu; Florent Couineau; Quentin Lisan; Lise Crevier-Buchman; Jerome R Lechien
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

Review 7.  Current Advances in Robotics for Head and Neck Surgery-A Systematic Review.

Authors:  Felix Boehm; Rene Graesslin; Marie-Nicole Theodoraki; Leon Schild; Jens Greve; Thomas K Hoffmann; Patrick J Schuler
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

8.  Acceptance and adoption of transoral robotic surgery in Germany.

Authors:  Magis Mandapathil; Jens E Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-07       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.